The objective of this Phase I study is to determine the maximum tolerated doses (MTD) of docetaxel and carboplatin in combination, when given to patients with advanced solid tumors.
|Effective start/end date||10/1/95 → 9/30/97|
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.